Brian H. Kushner

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies”.

Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies

Journal of Hematology & Oncology(2022)10.1186/s13045-022-01383-4

N/A

1.8DataRank · unranked

82 citations

Neeta Pandit‐Taskar, Brian H. Kushner, Pat Zanzonico, John L. Humm, Ursula Tomlinson +16 more

A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3427

N/A

0.317DataRank · unranked

7 citations

Shakeel Modak, Audrey Mauguen, Ellen M. Basu, Kim Kramer, Stephen S. Roberts +3 more

Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in Adults

JCO Precision Oncology(2023)10.1200/po.23.00138

N/A

0DataRank · unranked

8 citations

Brian H. Kushner, Stephen S. Roberts, Fiorella Iglesias Cardenas, Kim Kramer, Shakeel Modak +1 more

Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease

Frontiers in Oncology(2023)10.3389/fonc.2022.1106597

N/A

0DataRank · unranked

3 citations

Brian H. Kushner, Angela Di Giannatale, Gunes Gundem, Shanita Li, Stephen S. Roberts +5 more

Stage 4N neuroblastoma before and during the era of anti‐GD2 immunotherapy

International Journal of Cancer(2023)10.1002/ijc.34693

N/A

0DataRank · unranked

2 citations

Michael P. LaQuaglia, Fiorella Iglesias Cardenas, Ellen M. Basu, Justin T. Gerstle, Kim Kramer +5 more

Long Prime–Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine

Vaccines(2024)10.3390/vaccines12060587

N/A

0DataRank · unranked

2 citations

Audrey Mauguen, Shakeel Modak, Ellen M. Basu, Yi Feng, Brian H. Kushner +2 more

Ovarian function in female survivors of high‐risk neuroblastoma

Pediatric Blood & Cancer(2024)10.1002/pbc.31181

N/A

0DataRank · unranked

3 citations

Amelia DeRosa, Caroline E. Kostrzewa, Chaya S. Moskowitz, Kimberly A. Bogardus, Zoltan Antal +10 more

Evolutionary Strategies AI Addresses Multiple Technical Challenges in Deep Learning Deployment: Proof-of-Principle Demonstration for Neuroblastoma Brain Metastasis Detection

Journal of Imaging Informatics in Medicine(2024)10.1007/s10278-024-01165-z

N/A

0DataRank · unranked

4 citations

Hrithwik Shalu, David A. Gutman, Andrei I. Holodny, Shakeel Modak, Ellen M. Basu +5 more

Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience

Practical Radiation Oncology(2024)10.1016/j.prro.2023.12.008

N/A

0DataRank · unranked

1 citations

Dana L. Casey, Kathryn R. Tringale, Joshua N. Honeyman, Nicole J.C. Narayan, Michael P. LaQuaglia +6 more

Treatment and revaccination of children with paraneoplastic opsoclonus‐myoclonus‐ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience

Pediatric Blood & Cancer(2020)10.1002/pbc.28319

N/A

0DataRank · unranked

8 citations

Cheryl Fischer, Yi‐Chih Lin, Ellen M. Basu, Brian H. Kushner, Kevin C. De Braganca +2 more

Local Control With Reduced-Dose Radiation Therapy for High-Risk Neuroblastoma: Results From a Prospective Clinical Trial

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.09.068

N/A

0DataRank · unranked

0 citations

Dana L. Casey, Brian H. Kushner, Shakeel Modak, Zhigang Zhang, Michael P. LaQuaglia +6 more

Early‐phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting

Cancer(2022)10.1002/cncr.34445

N/A

0DataRank · unranked

14 citations

Judith G. Villablanca, Barbara Hero, Brian H. Kushner, Keith Wheatley, Klaus Beiske +9 more